Publications by authors named "Andrea Capra"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

117

Total Likes

80

Extended Reach

242,786

Social Features

43
B
Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial.
Sara Bringhen, Lorenzo Cani, Nicola Giuliani, Silvia Mangiacavalli, Giulia Benevolo, Andrea Capra

Haematologica· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurements of the quantum yield of silicon using Geiger-mode avalanching photodetectors.
Harry Lewis, Mahsa Mahtab, Fabrice Retière, Austin De St Croix, Kurtis Raymond, Andrea Capra

Eur Phys J C Part Fields· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing.
Stefania Oliva, Elisa Genuardi, Laura Paris, Mattia D'Agostino, Jennifer Rogers, Andrea Capra

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial.
Elena Zamagni, Stefania Oliva, Francesca Gay, Andrea Capra, Delia Rota-Scalabrini

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Roberto Mina, Pellegrino Musto, Delia Rota-Scalabrini, Laura Paris, Barbara Gamberi, Andrea Capra

Lancet Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
Mattia D'Agostino, David A Cairns, Juan José Lahuerta, Ruth Wester, Uta Bertsch, Andrea Capra

J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.
Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini, Laura Paris, Sonia Morè, Andrea Capra

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Francesca Gay, Pellegrino Musto, Delia Rota-Scalabrini, Luca Bertamini, Angelo Belotti, Andrea Capra

Lancet Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Andrea Capra

Blood Cancer J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients.
Gian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, Massimo Offidani, Paolo Corradini, Andrea Capra

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D'Agostino, Massimo Offidani, Andrea Capra

Blood· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.
Stefania Oliva, Davine Hofste Op Bruinink, Lucie Rihova, Mattia D'Agostino, Lucia Pantani, Andrea Capra

Blood Cancer J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies.
Roberto Mina, Francesca Bonello, Maria Teresa Petrucci, Anna Marina Liberati, Concetta Conticello, Andrea Capra

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score.
Mattia D'Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Andrea Capra

Blood Cancer J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing.
Mattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, Even H Rustad, Elisa Genuardi, Andrea Capra

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study.
Roberto Mina, Angelo Belotti, Maria Teresa Petrucci, Renato Zambello, Andrea Capra

Blood Cancer J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis